Abstract
Although dipyridamole was identified as a potential antithrombotic agent many years ago,(1) its effectiveness as a single agent in secondary prevention of arterial thrombosis in man has never been proven in properly conducted clinical trials with sufficient power. In many clinical trials it has been tested in combination with aspirin, and until recently meta-analyses have failed to show any significant benefit of the combination of aspirin and dipyridamole beyond that shown with aspirin alone.(2,3).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
